Gladstone NOW: The Campaign Join Us on the Journey✕
From penicillin to organ transplants, so many important discoveries have dramatically changed healthcare and medicine over the past decades. But what’s really behind all this progress?
The key to all these developments is basic biomedical research. Science is accelerating at an unprecedented pace and opening new paths in research that weren’t possible a few years ago.
Scientists here at Gladstone Institutes are leveraging state-of-the-art scientific tools and creating technologies to find new ways to prevent and treat disease. They are discovering how the cells and molecules in our bodies work, providing the building blocks that will one day benefit patients suffering from diseases ranging from heart disease, Alzheimer’s and other neurologic diseases and immunologic disorders.
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
From fundamental insights to translational advances, here’s how Gladstone researchers moved science forward in 2025.
Gladstone Experts Alzheimer’s Disease Autoimmune Diseases COVID-19 Neurological Disease Genomic Immunology Cardiovascular Disease Data Science and Biotechnology Infectious Disease Conklin LabIn this video, Gladstone scientists share how they used stem cells, gene editing, and AI to identify a gene driving heart defects in Down syndrome—and how reducing its levels in mice restored normal heart development, offering hope for future treatments
Gladstone Experts Cardiovascular Disease Data Science and Biotechnology Pollard Lab Srivastava Lab AI Big Data CRISPR/Gene Editing Human Genetics Stem Cells/iPSCsIn this video, Steve Finkbeiner and Jeremy Linsley showcase Gladstone’s groundbreaking “thinking microscope”—an AI-powered system that can design, conduct, and analyze experiments autonomously to uncover new insights into diseases like Alzheimer’s, Parkinson’s, and ALS.
Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Neurological Disease Finkbeiner Lab AI Big Data